All publications

Export 168 results:
Author Title Type [ Year(Asc)]
2008
Grover D, Copas A, Green H, Edwards SG, Dunn DT, Sabin CA, Phillips AN, Allen E., Pillay D.  2008.  What is the risk of mortality following diagnosis of multidrug-resistant HIV-1? J Antimicrob Chemother. 61:705-13.
2007
Nebbia G, Sabin CA, Dunn DT, Geretti AM.  2007.  Emergence of the H208Y mutation in the reverse transcriptase (RT) of HIV-1 in association with nucleoside RT inhibitor therapy. J Antimicrob Chemother. 59:1013-6.
Fox J, Dudaz A, Green H, Dunn DT, Kaye S, McClure M, Fidler S, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2007.  Epidemiology of non-B clade forms of HIV-1 in MSM in the UK. 13th Annual Conference of the British HIV Association, 25-28 April 2007.
UK Collaborative Group on HIV Drug Resistance, UK Collaborative HIV Cohort Study(UK CHIC), UK Register of HIV Seroconverters.  2007.  Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom. AIDS. 21:1035-9.
Cane P A, Green H, Fearnhill E, Dunn DT.  2007.  Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase. AIDS. 21:447-55.
Green H, Tilston P, Fearnhill E, Dunn DT, UK HIV Drug Resistance Database.  2007.  The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the UK. 13th Annual Conference of the British HIV Association, 25-28 April 2007.
Green H, Tilston P, Fearnhill E, Dunn DT, UK HIV Drug Resistance Database.  2007.  The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the UK. 2nd International Workshop on HIV Transmission, 26-28 August 2007.
Dunn DT, Green H, Fearnhill E.  2007.  Time trends in HIV drug resistance in ART-experienced patients in the UK: impact of improved treatments and boosted protease inhibitors. 13th Annual Conference of the British HIV Association, 25-28 April 2007.
Dunn DT, Pillay D.  2007.  UK HIV drug resistance database: background and recent outputs. J HIV Ther. 12:97-8.
2006
Gifford RJM, de Oliveira T, Rambaut A, Myers R.E, Gale C.V, Dunn DT, Shafer R., Vandamme A.M, Kellam P, Pillay D.  2006.  Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity. AIDS. 20:1521-9.
Lewis F, Fearnhill E, Murray R, Pillay D, Dunn DT, Leigh Brown A, UK Collaborative Group on HIV Drug Resistance.  2006.  Bayesian models in the analysis of HIV drug resistance data from the UK HIV Drug Resistance Database. 15th International HIV Drug Resistance Workshop, 13-17 June 2006.
Geretti AM, Sabin CA, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2006.  The H208Y mutation in reverse transcriptase is significantly associated with NRTI exposure, M184V and TAM mutation pathways. 15th International HIV Drug Resistance Workshop, 13-17 June 2006.
Easterbrook P, Welz T, UK HIV Drug Resistance Database.  2006.  Impact of HIV-1 subtype on genotypic resistance to protease inhibitors in the United Kingdom. 13th Conference on Retroviruses and Opportunistic Infections, 5-8 February 2006.
Gifford RJM, Kellam P, Dunn DT, Pillay D, UK HIV Drug Resistance Database.  2006.  The impact of structural and functional constraints acting at the nucleic acid level on the evolution of drug resistance in HIV-1. 15th International HIV Drug Resistance Workshop, 13-17 June 2006.
2005
Pillay D, Green H, Matthias R, Dunn DT, Phillips AN, Sabin CA, Evans B..  2005.  Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. J Infect Dis. 192:967-73.
Phillips AN, Dunn DT, Sabin CA, Pozniak A, Matthias R, Geretti AM, Clark J, Churchill D, Williams I, Hill T et al..  2005.  Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS. 19:487-94.
Geretti AM, Sabin CA, Dunn DT, Nebbia G, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2005.  Mutations at reverse transcriptase (RT) codons G196, Q207, H208, R211 and I214 are associated with drug experience and specific RT mutation patterns. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Dunn DT, UK HIV Drug Resistance Database.  2005.  Patterns of thymidine analogue mutations (TAMS) in samples sent for routine HIV drug resistance testing. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Grover D, Allen L, Edwards SG, Green H, Copas A, Forsyth S, Pillay D, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2005.  Predictors of death and response to therapy in patients with multi (three)-class drug resistant (MDR) HIV in the UK. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Cane P A, Chrystie I, Dunn DT, Evans B., Geretti AM, Green H, Phillips AN, Pillay D, Porter K, Pozniak A et al..  2005.  Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study. BMJ. 331:1368.